Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,013 across all filing types
Latest filing 2021-09-16 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于收到注射用艾司奥美拉唑钠药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the receipt of a drug registration certificate by a subsidiary of the company. It contains no financial data, no report or financial statements, and no mention of any meeting or voting results. It is a regulatory announcement about product approval and market impact risks. The document length is short (784 characters) and it is clearly an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-09-16 Chinese
2021年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from a company's second extraordinary general meeting in 2021. It details the meeting date, attendance, voting procedures, and voting results on specific proposals, including a share repurchase agreement. It also includes legal opinions confirming the meeting's compliance with laws and company bylaws. The content focuses on the official announcement of voting results from a shareholder meeting rather than the meeting materials or the full report. The document length is short (1696 characters), consistent with a voting results announcement rather than a full report or presentation. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-09-14 Chinese
2021年第二次临时股东大会法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening and procedures of the 2021 second extraordinary general meeting (临时股东大会) of 福安药业（集团）股份有限公司. It details the legality of the meeting's notice, attendance, voting procedures, and resolutions passed. It does not contain financial statements or results but focuses on the legal compliance of the shareholders' meeting process and resolutions. This type of document is not an annual or interim report, earnings release, or management discussion. It is a legal opinion related to a shareholders' meeting, which is typically classified under Regulatory Filings (RNS) as it does not fit other specific categories and is a compliance/legal document.
2021-09-14 Chinese
关于子公司收到克林霉素磷酸酯注射液药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a subsidiary receiving a drug registration certificate from the National Medical Products Administration. It contains no financial statements, no management discussion, no voting results, no executive changes, no earnings data, and no detailed financial or strategic presentation. The document is short (926 characters) and primarily informs about regulatory approval related to a pharmaceutical product. This fits best under a general regulatory announcement category rather than a financial report or meeting material. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-09-09 Chinese
第四届董事会第二十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board meeting of the company 福安药业（集团）股份有限公司. It details the meeting date, attendance, voting method, and the approval of a specific proposal regarding an employee stock ownership plan extension. There is no financial data, no detailed report, and no mention of annual or quarterly results. The document is a formal announcement of board decisions, which fits the category of Board/Management Information (MANG). The document length is short and focused on board resolutions, not a full report or presentation.
2021-09-03 Chinese
关于第一期员工持股计划延期一年的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the extension of the duration of the company's first employee stock ownership plan by one year. It details the background of the plan, the share transfer agreements, the lock-up period, and the approval process for the extension. There are no financial statements or detailed financial data presented. The document is a formal announcement about a capital-related plan (employee stock ownership plan) and its extension, which fits best under the category of Share Issue/Capital Change announcements. It is not a full report, nor a regulatory filing or a management report. The document length is short (1934 characters), and it is a direct announcement, not a report publication notice or certification. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2021-09-03 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.